• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home AI Roundup

Punjab launches AI screening program this week

byDeepti Shroff
September 30, 2025
in AI Roundup, Ophthalmology, Public Health
Reading Time: 2 mins read
Blindness and visual impairment decreasing worldwide
Share on FacebookShare on Twitter

1. Punjab launched India’s first large-scale AI screening program for cancer and eye disease.

2. The initiative aims to perform 900 screenings daily across rural districts, with physicians verifying all AI results.

On September 18, 2025, the government of Punjab launched an AI-enabled screening initiative for breast cancer, cervical cancer, and vision impairment across eight districts. The program is barely a week old and marks India’s first large-scale, state-level adoption of AI in population screening. Cancer incidence in Punjab reached 42,288 new cases in 2024, a 7 percent rise from the prior year, while only 0.3 percent of women nationally have ever been screened for breast cancer. The initiative deploys devices such as Thermalytix for breast imaging, Smart Scope for cervical cancer, and Forus Health autorefractometers for vision checks. The government has set ambitious goals, aiming for 600 eye exams and 300 cancer screenings daily across rural sites. The program ensures that AI highlights concerning cases, but physicians are required to confirm findings before further action. This safeguard preserves medical accountability while expanding screening reach. The rollout reflects a deliberate push to improve equity, since rural and underserved populations face the greatest delays in diagnosis. Because the program began only days ago, it is being closely observed as a real-time test case for scalability. International health experts are framing this as one of the most recent and ambitious applications of AI in public health. The initiative could cut late-stage cancer diagnoses, which are a major driver of poor outcomes in India. By pairing AI triage with clinician oversight, the program aims to combine efficiency with safety. Early field reports suggest strong community interest and rapid adoption in district hospitals. If results are positive, the Punjab model may be expanded to other states and adapted for diseases beyond oncology and vision. This rollout, launched just last week, underscores how AI is already reshaping frontline care in entire populations. The fact that it is happening now adds urgency to global conversations about AI’s role in reducing health disparities.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Tags: AIBreast Cancerbreast imagingcancercervical cancereye diseasepublic healthsreening
Previous Post

Dupilumab treatment is associated with improved mortality but increased risk of lymphoma in asthma patients

Next Post

Use of etomidate and ketamine is associated with similar rates of peri-intubation hypotension and mortality

RelatedReports

Oncology

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

October 5, 2026
A collection of symbolic items such as a microscope
Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Artificial Intelligence

Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being

September 16, 2026
Next Post
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

Use of etomidate and ketamine is associated with similar rates of peri-intubation hypotension and mortality

Record-based algorithm may improve lung cancer screening follow-up

Lilly unveils TuneLab AI platform for biotechs

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Left atrial appendage closure is safe and effective in atrial fibrillation

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Low-dose radiotherapy may be effective as a short-term therapeutic option in knee osteoarthritis
  • Physician edits to artificial intelligence (AI)-generated messages to patients were associated with different response time burdens
  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.